PALOMA-3: Palbociclib plus fulvestrant improved progression-free survival in hormone receptor-positive advanced breast cancer | Prof Lisa Carey at ASCO 2015

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Lisa A. Carey, MD, of the University of North Carolina, Chapel Hill, NC, discusses the results of the double-blind, phase 3 PAL... Author: EMJ Added: 07/21/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts